|
Market Closed -
NYSE
16:02:20 2026-11-10 EST
|
5-day change | 1st Jan Change | ||
| 110.46 USD | -0.05% |
|
+0.27% | -11.84% |
| 11-10 | Abbott Announces Availability Of Panbio COVID-19/Flu A&B Self-Test | CI |
| 11-10 | BofA Adjusts Price Target on Abbott Laboratories to $125 From $115 | MT |
| Market Cap | 191B 171B 158B 143B 272B 17,976B 279B 1,888B 753B 9,582B 718B 703B 30,372B | P/E 2026 * |
36.6x | P/E 2027 * | 26.6x |
|---|---|---|---|---|---|
| Enterprise Value | 215B 193B 177B 161B 305B 20,188B 313B 2,121B 845B 10,761B 807B 789B 34,110B | EV / Sales 2026 * |
4.3x | EV / Sales 2027 * | 3.95x |
| Free-Float |
86.21% | Yield 2026 * |
2.35% | Yield 2027 * | 2.5% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
|
Tradegate
| ABL | Real-time | |
|
London S.E.
| ABT | Delayed | |
|
Deutsche Boerse AG
| ABL | Delayed | |
|
Borsa Italiana
| 1ABT | End-of-day quote | |
|
Xetra
| ABL | Delayed | |
|
Boerse Muenchen
| ABL | Real-time | |
|
CBOE
| Real-time | ||
|
Bulgaria S.E.
| ABL | End-of-day quote | |
|
Mexican S.E.
| ABT * | End-of-day quote | |
|
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
|
Swiss Exchange
| ABT | Delayed | |
|
Börse Stuttgart
| ABL | Delayed | |
|
Santiago S.E.
| ABT | End-of-day quote | |
|
Santiago S.E.
| ABTCL | End-of-day quote | |
|
CBOE
| ABT | Real-time | |
|
Wiener Boerse
| ABT | End-of-day quote | |
|
Lima
| ABTUS | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 day | -0.05% | ||
| 1 week | +0.27% | ||
| Current month | +4.01% | ||
| 1 month | +10.90% | ||
| 3 months | +2.46% | ||
| 6 months | +31.00% | ||
| Current year | -11.84% |
| 1 week | 108.72 |  | 117.07 |
| 1 month | 97.67 | | 117.07 |
| Current year | 81.97 | | 129.46 |
| 1 year | 81.97 | | 132.02 |
| 3 years | 81.97 | | 141.23 |
| 5 years | 81.97 | | 142.6 |
| 10 years | 37.38 | | 142.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 2020-03-30 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 2023-08-31 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 2011-12-08 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 2011-12-08 |
Daniel Starks
BRD | Director/Board Member | 71 | 2017-02-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/26 | Free | Director | 333 | 0.0000% | ||
| 9/30/26 | Free | Director | 318 | 0.0000% | ||
| 9/30/26 | Free | Director | 381 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.05% | +0.27% | -12.58% | +18.08% | 191B | |
| -1.17% | +2.32% | +10.18% | +44.94% | 126B | |
| -0.44% | +5.70% | -8.91% | +19.73% | 124B | |
| -1.57% | +0.37% | -39.17% | +6.93% | 98.14B | |
| +0.85% | +3.22% | -3.32% | +77.17% | 65.98B | |
| -1.23% | +7.05% | +19.55% | -8.45% | 58.63B | |
| -1.42% | +3.72% | -1.67% | +66.36% | 55.67B | |
| +1.42% | -5.09% | -7.57% | +50.74% | 48.78B | |
| +1.08% | +2.42% | +4.85% | -6.69% | 36.03B | |
| +0.49% | +21.65% | - | - | 35.77B | |
| Average | -0.20% | +4.24% | -4.29% | +29.87% | 84B | |
| Weighted average by Cap. | -0.40% | +3.32% | -6.76% | +28.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 49.95B 44.74B 41.2B 37.44B 70.86B 4,691B 72.74B 493B 196B 2,501B 187B 183B 7,926B | 53.5B 47.92B 44.13B 40.11B 75.9B 5,024B 77.91B 528B 210B 2,678B 201B 196B 8,489B |
| Net income | 5.64B 5.05B 4.65B 4.23B 8.01B 530B 8.22B 55.67B 22.19B 283B 21.18B 20.73B 895B | 7.66B 6.86B 6.32B 5.74B 10.87B 719B 11.15B 75.56B 30.12B 383B 28.74B 28.13B 1,215B |
| Net Debt | 23.55B 21.1B 19.43B 17.66B 33.42B 2,212B 34.3B 232B 92.63B 1,179B 88.39B 86.51B 3,738B | 20.14B 18.04B 16.61B 15.1B 28.57B 1,891B 29.33B 199B 79.2B 1,008B 75.57B 73.97B 3,196B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-10 | US$110.46 | -0.05% | 6,541,016 |
| 26-11-09 | US$110.51 | +0.53% | 7,838,054 |
| 26-11-06 | US$109.93 | -3.23% | 8,345,288 |
| 26-11-05 | US$113.60 | -1.65% | 10,285,272 |
| 26-11-04 | US$115.51 | +5.59% | 12,712,205 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
